CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 65  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.1289
LYS 10.0134
GLU 20.0387
LEU 30.0052
ARG 40.0068
CYS 50.0019
GLN 60.0043
CYS 70.0057
ILE 80.0251
LYS 90.0423
THR 100.0170
TYR 110.0281
SER 120.0208
LYS 130.0142
PRO 140.0279
PHE 150.0296
HIS 160.0090
PRO 170.0020
LYS 180.0122
PHE 190.0064
ILE 200.0067
LYS 210.0072
GLU 220.0091
LEU 230.0104
ARG 240.0085
VAL 250.0117
ILE 260.0052
GLU 270.0194
SER 280.0127
GLY 290.0193
PRO 300.0152
HIS 310.0085
CYS 320.0066
ALA 330.0169
ASN 340.0160
THR 350.0104
GLU 360.0031
ILE 370.0169
ILE 380.0087
VAL 390.0058
LYS 400.0050
LEU 410.0067
SER 420.0030
ASP 430.0066
GLY 440.0025
ARG 450.0090
GLU 460.0044
LEU 470.0044
CYS 480.0087
LEU 490.0146
ASP 500.0346
PRO 510.0395
LYS 520.0262
GLU 530.0141
ASN 540.0222
TRP 550.0212
VAL 560.0178
GLN 570.0179
ARG 580.0192
VAL 590.0209
VAL 600.0109
GLU 610.0135
LYS 620.0151
PHE 630.0063
LEU 640.0121
LYS 650.0223
ARG 660.0374
ALA 670.0571
GLU 680.1114
ASN 690.1289

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.